Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Biotechnology startup, Innate Immunity, expands to Fort Collins to collaborate with Innosphere Ventures and Colorado State University

10/29/2020 | 09:59am EST

Fort Collins, Colorado, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Innate Immunity, a four year-old biotechnology startup focused on plant and crop health, has announced their expansion to Colorado as the company will operate out of laboratory and office space in the Innosphere Ventures building in Fort Collins, CO. Innate Immunity is currently based at the New Mexico Consortium Laboratory in Los Alamos, New Mexico. Innate is working to combat some of the most devastating bacterial, viral, and fungal diseases affecting cherished crops including grape, citrus, apple, and pear.

“We have collaborative and rich partnerships with leading industry, research and government entities,” said Michelle Miller, co-founder of Innate Immunity. “Expanding our operations to Fort Collins has allowed up to better work with Colorado State University on our infection greenhouse trials.” In addition to their field trials with CSU, Innate Immunity is also actively underway with field trials in New Mexico, Texas, Florida, and California.

“I’m excited to be working with a biotech startup like Innate Immunity because they’re lean, highly-productive, and have a talented business entrepreneur of Michelle Miller scaling the company,” said Ben Walker, Innosphere client manger and director of the NoCoBio Cluster. “We’re excited to have them located at Innosphere, and their co-founders can count on the support of our commercialization program and our bioscience community.”

Innate Immunity has developed a novel chimeric peptide topical plant therapy that is a new approach to clearing plant diseases from the host. As an example, one of Innate Immunity’s products aims to be the long-term solution to Huanglongbing (HLB), which is one of the most destructive diseases of citrus fruits and continues to spread across the globe with rapid infections occurring in Brazil, China, Mexico and the US. In 2019, plant diseases caused the production of oranges to be down 73% and grapefruit production down 89% since 2003. While this is just one crop and plant health issue that Innate Immunity is solving, the company has many products in development that prevent pathogen-induced diseases.

A spinoff company from Innate Immunity, LLC is biotech startup called Immunological Solutions, Inc. that focuses on utilizing the natural human response towards infection as a method to combat antibiotic resistant strains causing disease and chronic illnesses. Next steps for this spinoff company is to complete validation of their therapeutic approach to engineer human-derived new peptides and proteins to treat multiple diseases.

For more information on Innate Immunity or its spinoff startup, Immunological Solutions, contact Michelle Miller, co-founder and CEO at michelleh@hddd.org or 505-310-5711.

Attachments

Michelle Miller
Innate Immunity
michelleh@hddd.org

© GlobeNewswire 2020
Latest news "Companies"
05:51pVALID SOLUÇÕES S A : Payment of Interest related to 7th Debenture Issue
PU
05:51pFIRST HAWAIIAN : FHB Investor Presentation, November / December 2020
PU
05:50pOliveX Holdings Limited Completion of Volution Asset Acquisition
AW
05:49pPETCO : Files Registration Statement for Proposed Initial Public Offering
PR
05:48pUNITED RENTALS : BetterInvesting™ Magazine Chooses United Rentals As "Growth" Stock and Merck As "Undervalued" For March 2021 Issue
PR
05:47pHIGHLIGHTS FROM ANDY JASSY'S AWS RE : Invent 2020 Keynote
PU
05:46pFLOWERS FOODS : Amended - Flowers Foods Issues Voluntary Recall Of Two Canyon Bakehouse Products Due To Possible Presence Of Gluten
PR
05:46pJOHNSON & JOHNSON : Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
PU
05:46pGlobal Dairy Food Market is Accelerating at 2% CAGR | $ 82.65 Billion Incremental Growth During 2020-2024 | Technavio
BU
05:44pROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN
GL
Latest news "Companies"